Interaction of Personality and Treatment Conditions Associated with Success in a Smoking Control Program

Jacobs, Martin; Spilken, Aron Z.; Norman, Martin M.; Wohlberg, Gerald W.; Knapp, Peter H.

doi:10.1097/00006842-197111000-00007

Cited by 50 publications

(17 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This is reminiscent of findings over short periods of time in clinic studies by Schwartz and Dubitzky," Thompson and Wilson,43 and Jacobs, et al 44 We also found this to be the case for spontaneous smoking withdrawal in our random sample of Buffalo.7…”

Section: Support Of Spousesupporting

confidence: 83%

Five year follow-up of a smoking withdrawal clinic population.

West¹,

Graham²,

Swanson³

et al. 1977

Am J Public Health

102

View full text Add to dashboard Cite

Eight hundred volunteers who attended smoking clinics at Roswell Park Memorial Institute from 1964-1965 were followed up five years later to ascertain their current smoking status. From three waves of a mailed questionnaire, plus a telephone campaign, we obtained 559 usable responses. The relationship between smoking status at the five-year follow-up and clinic protocols and selected social and psychological characteristics as determined during the clinics were examined.Of those individuals contacted five years after the clinic, 17.8 per cent were not smoking. Variations inIn the early 1960s the Surgeon General of the United States became actively involved in evaluating the evidence relating lung cancer to cigarette smoking. From these evaluations, definitive reports evaluating the literature linking lung cancer to smoking were published' and measures were sought to deal with this problem. One method which we applied was the smoking withdrawal clinic. We now have had the opportunity to examine the smoking status, and factors related to it, of 559 patients five years after they attended a series of clinics at Roswell Park Memorial Institute.We were concerned with a number of questions: What proportion of those attending clinics are successful over the long term? Do variations in clinic procedure result in different levels of success? What are the characteristics of those who, five years after attendance, had succeeded or failed in their attempt to withdraw from smoking?In studying such long-term behavior change, we were guided by the sociological literature dealing with this phenomenon. The most commonly studied behavior changes have been incremental ones: those where new behaviors have replaced old ones. Hypotheses dealing with incremental behavior, however, may also be applicable to the study of decremental behavior, the elimination of behavioral patterns with no replacement, such as smoking cessation.The relevant literature suggests that behavior change is more likely when the innovation is compatible with previously held ideas, values, and behavioral patterns; when the function of the new behavior is understood; when the new behavior is seen by the adopter as personally advantageous over old behavior; when the decision to adopt is reversible; when old behavior is feasible to give up, for example, where physiologic dependence is not involved; and when influential individuals in the subject's milieu accept or support the innovation.2Specifically regarding smoking behavior, we hypothesized that smoking cessation would be negatively associated with the amount of habituation involved and positively associated with possession of a personal psyche which can withstand withdrawal trauma, a knowledge of the ill effects of smoking, a perceived personal threat of lung cancer, and behavior and support from others in the personal milieu which is compatible with withdrawal. Almost all of our hypotheses were confirmed. MethodsFrom August 1963 to June 1965, 25 different smoking cessation clinics were held at Roswell...

show abstract

Section: Support Of Spousesupporting

confidence: 83%

Five year follow-up of a smoking withdrawal clinic population.

West¹,

Graham²,

Swanson³

et al. 1977

Am J Public Health

102

View full text Add to dashboard Cite

show abstract

“…These follow-up points have included immediately post-treatment [as in a study by Keutzer (37)], two weeks post-treatment (39), three-month follow-up (40), six-week follow-up (41), one-year follow-up (42), and three to four-year follow-ups (38,16).…”

Section: Follow-up Diff Erences and Deficienciesmentioning

confidence: 99%

Control of Cigarette Smoking from a Psychological Perspective

Benfari¹,

Ockene²,

McIntyre³

1982

Annu. Rev. Public Health

View full text Add to dashboard Cite

“…There are no long term studies of doxepin and imipramine, but short term trials suggest that imipramine does not significantly reduce cigarette consumption compared to a no-medication control [337]. Although doxepin improves cravings, two months sustained abstinence rates are similar to placebo [338].…”

Section: Relative Efficacymentioning

confidence: 99%

New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?

et al. 2016

View full text Add to dashboard Cite

A wide range of support is available to help smokers to quit and aid attempts at harm reduction, including three first-line smoking cessation medications: nicotine replacement therapy, varenicline and bupropion. Despite the efficacy of these, there is a continual need to diversify the range of medications so that the needs of tobacco users are met. This paper compares the first-line smoking cessation medications to: 1) two variants of these existing products: new galenic formulations of varenicline and novel nicotine delivery devices; and 2) twenty-four alternative products: cytisine (novel outside of central and eastern Europe), nortriptyline, other tricyclic antidepressants, electronic cigarettes, clonidine (an anxiolytic), other anxiolytics (e.g. buspirone), selective 5-hydroxytryptamine Key points: This paper reviews 26 pharmacotherapies that have been investigated for tobacco harm reduction and smoking cessation alongside three first-line treatments (nicotine replacement therapy, varenicline and bupropion) on six criteria: relative efficacy, relative safety, relative cost, relative use, relative scope, and relative ease of use. Although many of these products are in the early stages of clinical trials, of all the medications considered, cytisine appears to offers the best prospect for the future, having established safety and efficacy and being very inexpensive. Electronic cigarettes have become very popular in some countries but efficacy and long-term safety compared with other treatment profiles require further consideration.

show abstract

Interaction of Personality and Treatment Conditions Associated with Success in a Smoking Control Program

Cited by 50 publications

References 12 publications

Five year follow-up of a smoking withdrawal clinic population.

Five year follow-up of a smoking withdrawal clinic population.

Control of Cigarette Smoking from a Psychological Perspective

New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?

Contact Info

Product

Resources

About